Skip to main content

Table 2 Univariate survival analysis

From: Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes

  DFS OS
  % events Mean survival, years (SE) p % events Mean survival, years (SE) p
GCDFP-15       0.044
Negative 30.3 5.85 (0.24)   19.3 7.07 (0.23)
Positive 25.1 6.67 (0.30) 0.052 13.9 7.75 (0.27)
HR       0.013
Negative 35.6 5.53 (0.36)   23.3 6.75 (0.34)
Positive 25.0 6.48 (0.23) 0.004 19.3 7.67 (0.34)
HER2       0.686
Negative 26.3 6.31 (0.22)   16.0 7.46 (0.21)
Positive 37.0 5.64 (0.40) 0.114 22.3 7.06 (0.24)
Biological tumor types       0.084
HR+/HER2- 23.2 6.61 (0.25)   13.7 7.71 (0.24)
HR+/HER2+ 33.8 5.86 (0.52)   16.9 7.45 (0.43)
HR-/HER2+ 43.6 4.98 (0.60)   30.8 6.23 (0.53)
HR-/HER2- 33.3 5.59 (0.42) 0.011 21.1 6.86 (0.41)
Age       0.046
< 50 years 24.9 6.48 (0.28)   12.8 7.79 (0.25)
> = 50 years 31.0 5.93 (0.26) 0.120 20.8 7.06 (0.24)
Histological type       0.915
Ductal/others 28.8 6.15 (0.20)   17.2 7.40 (0.19)
Lobular 10.0 6.42 (0.55) 0.309 17.4 6.82 (0.55)
grading       0.043
G1-2 26.4 6.42 (0.22)   16.1 7.54 (0.20)
G3 34.6 5.35 (0.41) 0.005 20.8 6.70 (0.40)
cT       0.001
cT1-2 20.8 6.90 (0.24)   12.4 7.88 (0.22)
cT3-4 43.9 4.93 (0.31) <0.0001 26.7 6.65 (0.31)
cN       <0.0001
cN0 22.4 6.91 (0.28)   11.4 8.12 (0.24)
cN+ 33.9 5.56 (0.26) <0.0001 22.5 6.75 (0.25)
  1. DFS: disease-free survival.
  2. OS: overall survival.
  3. SE: standard error.